Search Result "chronic myelo-monocytic leukaemia (CMML)"
Immunotherapy for Myeloproliferative Neoplasms (MPN)
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 1 Year: 2011 Page: 72-84
Author(s): Susanne Hofmann, Anna Babiak, Jochen Greiner
Tyrosine Kinases as Therapeutic Targets in BCR-ABL Negative Chronic Myeloproliferative Disorders
Journal: Current Drug Targets
Volume: 8 Issue: 2 Year: 2007 Page: 205-216
Author(s): Andreas Reiter, Christoph Walz, Nicholas C. P. Cross
Myelodysplastic/Myeloproliferative Neoplasms
Journal: Current Cancer Therapy Reviews
Volume: 8 Issue: 1 Year: 2012 Page: 52-65
Author(s): Cherie H. Dunphy
Serine-Threonine Protein Kinases CK1, CK2 and GSK3 in Normal and Malignant Haematopoiesis
Journal: Current Signal Transduction Therapy
Volume: 6 Issue: 1 Year: 2011 Page: 88-98
Author(s): Francesco Piazza, Sabrina Manni, Anna Colpo, Laura Quotti Tubi, Carmela Gurrieri, Gianpietro Semenzato
Myeloproliferative Neoplasms Including Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis, Chronic Neutrophilic Leukemia, and Myeloproliferative Neoplasm, Unclassifiable
Journal: Current Cancer Therapy Reviews
Volume: 8 Issue: 1 Year: 2012 Page: 14-29
Author(s): Robert P. Hasserjian
Targeting Immune Signaling Pathways in Clonal Hematopoiesis
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 28 Year: 2019 Page: 5262-5277
Author(s): Nessar Ahmad Azrakhsh,Patrycja Mensah-glanowska,Kristoffer Sand,Astrid Olsnes Kittang
Impact of Splicing Factor Mutations on Pre-mRNA Splicing in the Myelodysplastic Syndromes
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 1 Year: 2016 Page: 2333-2344
Author(s): Bon Ham Yip, Hamid Dolatshad, Swagata Roy, Andrea Pellagatti, Jacqueline Boultwood
WT1 Peptide Vaccine as a Paradigm for “Cancer Antigen-Derived Peptide”-Based Immunotherapy for Malignancies: Successful Induction of Anti-Cancer Effect by Vaccination with a Single Kind of WT1 Peptide
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9 Issue: 7 Year: 2009 Page: 787-797
Author(s): Yoshihiro Oka, Akihiro Tsuboi, Fumihiro Fujiki, Zheyu Li, Hiroko Nakajima, Naoki Hosen, Toshiaki Shirakata, Sumiyuki Nishida, Yusuke Oji, Ichiro Kawase, Haruo Sugiyama
Alterations within the Osteo-Hematopoietic Niche in MDS and their Therapeutic Implications
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 1 Year: 2016 Page: 2323-2332
Author(s): Anna Mies, Ekaterina Bulycheva, Inga Mandac Rogulj, Lorenz C. Hofbauer, Uwe- Platzbecker
Update on MDS Therapy: From Famine to Feast
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 8 Issue: 4 Year: 2010 Page: 187-198
Author(s): Preeti Chaudhary, Chirag Shah